In case of a history of venous thrombosis, anti-platelet therapy usually does not suffice but systemic anticoagulation is necessary and may be combined with ASS in the presence of a JAK2 mutation or cardiovascular risk factors [11]. Here, JAK2 is linked to Venous thrombosis.